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ABSTRACT
Background: Seasickness (SS) is an often hidden pathology, but one that can significantly disrupt work on 
board. The aim of the study is to evaluate the influence of SS on the workability of workers on board vessels.
Materials and methods: We performed a cross-sectional questionnaire study conducted on 250 oceano-
graphers in 2015 during 3 months. Based on the “Bos seasickness susceptibility questionnaire”, we created 
a specific questionnaire with 49 questions.
Results: 151 men and 72 women responded to the survey. 188 of them (91.7% of women and 80.8% of 
men) report being seasick, either occasionally (69%) or at each boarding where there is female predomi-
nance (23.6% vs. 11.3% for men). The major symptoms are nausea (82%) and vomiting (56%). 60% of 
the workers think that SS has an influence on the success of their mission, by first affecting their mood 
(50%), relationship (23%), and increased risk of accidents such as falls, accidents on machines or in la-
boratories (40%). Antinaupathic treatments also produce deleterious effects on their workstation. Women 
have higher risk of developing SS (odds ratio [OR] 2.6; 95% confidence interval [CI] 1.03–6.6; p = 0.04), 
more frequently taking medicines when ill (OR 4.1; 95% CI 1.27–13.2; p = 0.004) and coming with her 
own tablets (OR 2.3; 95% CI 1.3–4.1; p = 0.04).
Conclusions: Gender is a trending factor of SS. Information on SS clinical signs, impact and therapeutics 
could be prone to prevent sickness and impact of it on workability.
(Int Marit Health 2020; 71, 3: 160–165)
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INTRODUCTION
On board a ship, in addition to its own movement related 
to its propulsion and like for all nonstable natural environment, 
the sea could induce various movements back and forth 
(pitch) and from right to left (roll). This complex and random 
system of very low frequency vibratory type, due to changing 
weather conditions, is variable in time, frequency and intensity. 
The main result is a vertical translational movement directly 
related to waves’ height. The frequency of these vibrations 
is between 0.01 Hz in very calm condition and 1.5 Hz in 
bad weather and accelerations range from 0.01 to 0.8 g, 
sometimes even 1 g. At these frequencies, the body behaves 
like a single mass and the vibrations are fully transmitted in 
amplitude and acceleration (whole body vibrations) [1].
O’Hanlon and McCauley [2] have shown that, more than 
roll and pitch, which would ultimately play a secondary role, 
the primary cause of seasickness (SS) is above all the ac-
celeration of the vertical component of the movements. An 
abacus drawn from the theory of these authors was mod-
elled by Bos and Bles [1]. They compiled the frequency of 
the movement (in Hertz [Hz]), the acceleration (in m/s2) and 
the motion sickness incidence (MSI = percentage of subjects 
presenting a vomiting within 2 h) [1]. Thus, the maximum 
MSI would be reached for a movement frequency of 0.16 Hz 
and an acceleration of 5.4 m/s2. Lawther and Griffin [3] 
and after Davis and Hollowey [4] confirmed that the MSI 
was directly dependent on waves’ height and proportional 
to the movements’ vertical acceleration.
www.intmarhealth.pl
Int Marit Health 
2020; 71, 3: 160–165 
10.5603/IMH.2020.0029 
www.intmarhealth.pl 
Copyright © 2020 PSMTTM 
ISSN 1641–9251
ORIG INAL  ART ICLE
160
Seasickness is a consequence of a body positioning 
information disorder, involving simultaneously three compo-
nents: the vestibular system; the visual system, in particular 
tracking; and the proprioceptive and somatosensory system, 
in particular feet and nape of neck. The information produced 
by these three systems, transmitted to the brain centres, 
is compared with each other, but also compared with the 
information previously stored, to evaluate their coherence, 
which involves an adequate motor reaction of equilibration 
when they are coherent. In the case of SS, this information 
is conflicting and results in the appearance of clinical signs 
(sensory rearrangement theory of Reason and Brand [5]).
The chronology, number and intensity of the symptoms 
could be different in a very marked way according to the 
individual susceptibility of the individuals, the size of the 
ship, the nature, duration and importance of the movement 
and the environmental conditions (odours, heat, onboard 
places, position of the body and psychological conditions). 
We classically distinguish three phases: the beginning phase 
(anxiety, pallor, cold sweats, yawning, salivation, and drows-
iness), the state phase (nausea, vomiting and prostration) 
and evolution (in general resolution of signs within a few 
hours). In rare cases, the process can lead to acute dehy-
dration, imbalance of a preexisting health disorder such as 
diabetes, or disruption of treatment (not taking medication 
or rejection by vomiting).
Most studies and articles published in the field of motion 
sickness talked about road and air transport. Some also 
discussed about the mal du debarquement syndrome but SS 
in seafarers’ population is rarely discuss. Few studies have 
been published on the influence of SS and time to get used 
to life at sea on the workability of workers on board vessels.
The objectives of this study were to test certain epi-
demiological data found in the SS literature (prevalence, 
differences in relation to sex, study of clinical signs) and 
above all to assess the medical, economic and relational 
impact of this pathology on the implementation of profes-
sional tasks on board, highlighting the possible differences 
between men and women.
We studied these questions in a population of oceano-
graphic researchers from a French research centre.
MATERIALS AND METHODS
SURVEY METHODOLOGY
This is cross-sectional questionnaire study was conduct-
ed on 250 oceanographers in 2015 during 3 months. Based 
on the “Bos seasickness susceptibility questionnaire” [6], 
we created a specific questionnaire with 49 questions. Be-
fore the survey and during an onboard mission, it was tested 
in a smaller population. A health unit with an occupational 
nurse and a physician was located in the research centre. 
According to the health policies of the occupational health 
service, all workers who had onboard worktimes had been 
referred to the health unit for annual medical examinations. In 
2014, during examinations, employees of the health unit 
inform workers about the survey. In 2015, the questionnaires 
were sent individually by email. Workers had to send it back 
to the occupational health. They gave it in hand to hand to the 
nurse and confirm their consent. The inclusion criteria were: 
volunteer, being a researcher or a technician from the French 
research institute, regular onboard mission, fit at work and 
for navigation [7]. The onboard periods were either coastal 
or longer ocean-going missions.
STATISTICAL ANALYSIS
Statistical analysis was done by using Statistica software 
(TIBCO data sciences, Palo Alto California, USA). The quanti-
tative variables were described using the usual position and 
standard deviations. Categorical variables were presented as 
numbers (percentage). When conditions applied, the t-test 
was used. When needed, the Shapiro-Wilk test was used to 
test for normal distribution of data. Where variables were 
not normally distributed, non-parametric test (Mann-Withney 
U test) were used, otherwise. Crude odds ratio (OR) includ-
ing 95% confidence interval (CI) were calculated by binary 
regression. The alpha risk was set at 5% for all analyses. 
RESULTS
DATA COLLECTION
The source population included 250 workers: oceano-
graphers are researchers from different specialties (biolo-
gists, geologists, oceanographers, climatologists, physicists, 
chemists) who are interested in all aspects of the marine 
environment. We collected 223 questionnaire (151 men 
and 72 women), for a satisfactory response rate of 89.2%. 
The population and missions characteristics are sum-
marised in Table 1. 
Frequency, characteristics of SS and environmental 
factors effects are listed in Table 2.




Coastal and offshore 136 61
Offshore 58 26
Coastal 29 13
1 to 2 missions 133 59.6
> 2 missions 90 40.9
Total 223
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Table 2. Frequency, characteristics and environmental factors effects on seasickness
Number Per cent
Seasickness Yes 188 84.3
Never 35 15.7
Frequency Sometimes 154 81.9
Every time 34 18.1
With sea conditions Yes 166 89.2
No 20 10.8
Total 186
Vertical movements of the ship Yes 145 78.4
No 36 19.5
Total 185
Roll movements of the ship Yes 92 50
No 74 40.2
When first symptoms begin After some hours 167 88.8
Immediately after embarkment 20 10.6
Do you need time for getting used to the sea Yes 165 88.2
No 22 11.8
When symptoms disappeared 2/3 days 81 44
1 day 43 23.4
Few hours 34 18.5
Never 26 14.1
Symptoms are increased by Smell of gasoil 136 88.9
Smell of  cooking 83 54.2
Smell of tobacco 80 53.2
Poor ventilation 54 35.2
Influence of menstruation period Don’t know 45 62.5
No 20 27.8
Yes 7 9.7















Vomiting is the highest stage of SS and allows patients 
to be counted on a common basis (MSI). The Tables 3 and 4 
demonstrates respectively the SS symptoms, the impact of 
SS on workability and missions declared by workers.
When comparing two groups by gender, we find significant 
differences for SS (OR 2.6; 95% CI 1.03–6.6; p = 0.04), increased 
frequency in women for taking medicines when ill and coming 
with her own tablets (respectively OR 4.1; 95% CI 1.27–13.2; 
p = 0.004 and OR 2.3; 95% CI 1.3–4.1; p = 0.04) (Table 5).
Average boarding times were much lower for coastal mis-
sions (7.8 days) compared to offshore missions (25.7 days, 
p = 0.05).
FREQUENCY OF SEASICKNESS
The occurrence of SS was not related to the number of 
days on board (18 days for agents prone to SS and 21 days 
for the others, p = 0.1), age (p = 0.7) nor to the type of 
navigation (83.5% for offshore, 89.7% in coastal, p = 0.86).
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Table 4. Impact of seasickness (SS) on workability 
Number Per cent 
Are you afraid of SS before embarkment No 164 85.4
Yes 28 14.6
Due to SS, have you refused a mission No 183 95.8
Yes 8 4.2
Does SS have an impact on your mission? Yes 118 62.1
No 72 37.9
What kind? My own mood 86 75.4
Economical 43 37.7
Relationship with colleagues 33 28.9
Hard relationship with head of mission 5 4.4
In case of SS what do you do? Go on deck 106 56.4
Stay in my cabin 99 52.7
Take medicines 79 42
Nothing special 25 13.3
Type of medication Nothing 85 45.9
Mercalm 53 28.6
Scopolamine patches 40 21.6
Other: homeopathy, food and beverages 18 9.7
Stugeron 3 1.6
Do you feel embarrassed by SS No 119 64
Yes 67 36
What is the most embarrassing? Less reactive and active at work 61 88.4
To be sick in professional place 29 42
My colleagues could see me vomiting 18 26.1
Is SS have an impact on your time at workplace Yes 95 50.8
No 92 49.2
Table 5. Comparison by gender
Man Woman Odds ratio P












Stop after few hours














Afraid before mission (yes) 14 (11.3%) 14 (20.6%) 2.03 [0.9–4.57] 0.08
Take medicines* (yes)









No embarkation because of SS (yes)
Does SS have an impact on your mission? (no)













Do you feel embarrassed by SS 41 (33.3%) 26 (41.3%) 1.4 [0.75–2.62] 0.28
*p < 0.05 
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Table 6. Medicines 
Man Woman Total
Dimenhydrinate 18.5% 34.7% 23.8%
Cinnarizine 2% 0% 1.4%
Scopolamine’s patch 13.3% 27.8% 17.9%
Other (acupuncture, homeopathy) 7.3% 9.7% 8.1%
Are medicines efficient yes 75% 84% 79%
TAKING ANTI-SICKNESS TREATMENT
Table 6 summarises the behaviours implemented during 
the occurrence of a naupathy. The most widely used con-
ventional treatments were dimenhydrinate and cinnarizine 
(only 1% for the latter molecule because it is not marketed in 
France, despite its recognized effectiveness) for treatments 
in tablets and scopolamine per patch [6, 7]. 
DISCUSSION
The high level in response rate allows us to discuss 
our results.
We found, consistently to literature on the subject, gen-
der susceptibility for SS and mostly gastrointestinal disor-
ders. Due to SS, women are also more anxious before mission 
and taken medicines, but they less declared than men impact 
on work (concentration at work, psychological disorders). 
Due to extreme variability of its occurrence’ conditions 
it is hard to collect quantitative data on the incidence and 
prevalence of this pathology. Indeed, the weather, sea con-
ditions and number of patients during each mission are 
various. The estimated prevalence ranged from 25% to 
30% of American and British white populations in calm sea, 
increasing between 50% and 90% in heavy sea [8]. A recent 
publication on sailors from the French Merchant Navy gives 
a figure of 55% of sailors who would not be affected by SS 
at all [9]. In our study we found respectively a prevalence 
of 84% and 69% for “occasionally or systematically” and 
“occasionally” SS suffering. Lower frequency and duration 
of onboard mission in researchers could explain it. Con-
sistent with our results, gastrointestinal symptoms were 
more frequently declared with nausea (61%) and vomiting 
(48%) followed by yawning and drowsiness (30%) in the 
study involved by Turner and Griffin [10] or incidence of 
vomiting of 40% in 4915 passengers during 17 trips [8, 10]. 
Various percentages for apathy, fatigue and cold sweats 
are described [10]. But data in literature is based either 
on a calculation of the MSI in specific conditions [10]. In 
1976, Graybiel and Knepton [11] isolated a particular type 
of motion sickness, sopite syndrome, associating drowsi-
ness, yawning, disinterest in work, mood disorders, sleep 
disorders, but without digestive signs. We can classify in this 
syndrome only 5 people (2 men and 3 women).
Confirmed by our study, it is generally accepted that 
women are more often affected by SS than men [12, 13]. 
Our results shed particular light on this point by showing 
significant differences with an OR at 2.6. Moreover, some 
studies show a relationship between menstrual period and 
SS [14]. In our results, only 10.6% of women expressed 
greater sensitivity to SS during menstruation, 30% reported 
none. According to Cuomo-Granston and Drummond [15] 
female sex hormones may, at least in part, predispose 
individuals susceptible to motion sickness and migraine.  
In addition, adaptation to maritime conditions plays 
a role here. Sailors regularly on board are generally less 
prone to SS than passengers, since they incorporate move-
ment patterns conforming to the theory of Reason and 
Brand [5]. Like described by Bos and Bles [1] the effect of 
gender on SS susceptibility decreased inversely with age 
and no differences after 35 years were noted. 
Seasickness first poses a problem of self-esteem and 
relationships with others. In popular imagination, a seafarer 
is not (or should not be) prone to SS and, therefore, is prone 
to easily mock passengers affected by SS. The sick person 
therefore feels in a situation of psychological inferiority 
vis-à-vis those who are not or who do not want to admit it. 
In our population, 17% find it humiliating to be forced to 
vomit in front of work colleagues and 20% declared hav-
ing their relationship disrupted. It could also explain why 
women significantly come with their own medicines against 
SS and taken it more frequently than men who have to be 
“stronger” against SS. 
Seasickness and susceptibility to SS have a direct and 
indirect impact on workability. When they were ill, onboard 
workers went on deck or stayed in their cabin and daily time 
at work decrease. Indeed, most of workers declared that SS 
have an impact on their work tasks, concentration at work 
and own mood. Pisula et al. [16] have showed that vertical 
accelerations can cause cognitive impairment. Matsangas 
and McCauley [17] believe that the stress caused by SS 
and sopite syndrome is, in part, responsible for the deteri-
oration of cognitive performance. Valk mentions the fatigue 
and sleep disturbances caused by SS in the decline in 
performance rather than the movements of the ship itself 
[18]. The causes of SS accidents are in the risk of falling 
Int Marit Health 2020; 71, 3: 160–165
www.intmarhealth.pl164
(especially overboard while vomiting). But, whether in falls 
or in accidents at work such as accidents on machine tools 
or launching devices, or even jets of chemicals, it is mainly 
the movements of the ship, by bad time, which carry the 
risk, more than SS. In his thesis on 61 Finnish sailors, 
Spätgens [19] notes that 10% of them had SS at some point 
which prevented them from carrying out their usual tasks 
on board, 11% could only do light work, 38% had moderate 
discomfort in their work station and 42% were able to fully 
perform their tasks.
Side effects of drugs taken for SS could impact work ca-
pacities. Gordon [20] has shown that dimenhydrinate disrupts 
reaction and memorisation tests like digit span, which is not 
the case with cinnarizine and scopolamine. Also drowsiness 
and blurred vision have been noticed with such medicines.
To prevent impact of SS on work non-drug treatments 
such as optokinetic rehabilitation could be discussed. It 
gives good lasting results over time, and which can be 
proposed for subjects with uncontrollable SS [20, 21]. This 
treatment requires 20 sessions over a period of 3 months 
in a specialised environment. According to the authors, 71% 
of reeducated subjects are improved, compared to 12.5% 
of subjects subjected to placebo treatment [22]. It allows 
you to be less prone to SS and not taking medication during 
the mission. This therapy could also benefit to workers who 
declared higher susceptibility to SS. 
Our study is a self-declared study by questionnaire. 
A healthy worker effect is a possible bias with a population 
of selected oceanographers who regularly embarked. Indeed, 
in popular imagination, a seafarer is not (or should not be) 
prone to SS and, therefore, is prone to easily mock passengers 
affected by SS. The sick person therefore feels in a situation 
of psychological inferiority and do not declared it.
CONCLUSIONS
Seasickness is an often hidden pathology, but one that 
can significantly disrupt work on board. Gender is a trending 
factor of SS. Information on SS clinical signs, impact and ther-
apeutics could be prone to prevent sickness, other diseases 
linked to or imbalanced by SS and impact of it on workability. 
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